Prihlásiť sa Zaregistrujte sa zadarmo

Návratnosť imania spoločnosti Æterna Zentaris

Aká je hodnota metriky Návratnosť imania spoločnosti Æterna Zentaris?

Hodnota metriky Návratnosť imania spoločnosti Æterna Zentaris, Inc. je -83.44%

Aká je definícia metriky Návratnosť imania?



Návratnosť imania (Return on equity - ROE) je rentabilita vlastného imania. Vypočíta sa vydelením čistého príjmu za fiškálny rok vlastným imaním.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Návratnosť imania spoločností v sektore Health Care sektor na TSX v porovnaní so spoločnosťou Æterna Zentaris

Čomu sa venuje spoločnosť Æterna Zentaris?

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.

Firmy s metrikou návratnosť imania podobnou spoločnosti Æterna Zentaris



  • Hodnota metriky Návratnosť imania spoločnosti Galecto je -83.73%
  • Hodnota metriky Návratnosť imania spoločnosti CAP-XX je -83.71%
  • Hodnota metriky Návratnosť imania spoločnosti Cytocom Inc je -83.71%
  • Hodnota metriky Návratnosť imania spoločnosti ASLAN Pharmaceuticals Ltd je -83.58%
  • Hodnota metriky Návratnosť imania spoločnosti Aptorum je -83.53%
  • Hodnota metriky Návratnosť imania spoločnosti iDreamSky Technology je -83.50%
  • Hodnota metriky Návratnosť imania spoločnosti Æterna Zentaris je -83.44%
  • Hodnota metriky Návratnosť imania spoločnosti Patrys je -83.39%
  • Hodnota metriky Návratnosť imania spoločnosti good natured Products je -83.25%
  • Hodnota metriky Návratnosť imania spoločnosti Gold Mountain je -83.21%
  • Hodnota metriky Návratnosť imania spoločnosti FranceSoir e SA je -83.19%
  • Hodnota metriky Návratnosť imania spoločnosti Tiger Resource Plc je -83.11%
  • Hodnota metriky Návratnosť imania spoločnosti Greenlane Renewables je -82.95%